BANK OF INDIA MID CAP FUND

A Mid Cap Fund scheme from Bank of India Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF761K01GY4).

NAV ₹10.7400 on 16 November 2026.

Expense ratio

Total expense ratio 1.37% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 1.02%, brokerage 0.06%, transaction costs 0.00%, statutory levies including GST 0.29%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year7.1%16.2%-12.3%0.010.01

Too little NAV history for the 3, 5, 10-year figures.

Not ranked in its category: too few comparable funds have the history to rank against.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 98.3% of the portfolio.

  1. Aurobindo Pharma Limited — 5.95%
  2. Multi Commodity Exchange of India Limited — 4.96%
  3. Abbott India Limited — 4.72%
  4. Bharti Hexacom Limited — 4.07%
  5. One 97 Communications Limited — 3.49%
  6. Bank of Maharashtra — 3.11%
  7. Mankind Pharma Limited — 3.00%
  8. Quality Power Electrical Equipments Limited — 2.88%
  9. Meesho Limited — 2.78%
  10. Petronet LNG Limited — 2.75%

Plans

Other funds in Mid Cap Fund

All 34 funds in Mid Cap Fund · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.